Golden
LoginSign Up
Blueprint Genetics

Blueprint Genetics

Blueprint Genetics is a genetic testing company headquartered in Helsinki, Finland that was founded in 2012 by Juha Koskenvuo, Samuel Myllykangas, Tero-Pekka Alastalo, and Tommi Lehtonenis. The company offers genetic testing, genetic diagnostics, and clinical interpretation of genomic data for medical professionals.

Blueprint Genetics is a genomics company headquartered in Helsinki, Finland founded by Juha Koskenvuo, Samuel Myllykangas, Tero-Pekka Alastalo, and Tommi Lehtonenis in 2012. The company offers genetic testing, genetic analysis, and clinical interpretation of genomic data for medical professionals. The company tailors its genomic analysis for medical professionals working within specialty felids of medicine. Medical specialities supported by Blueprint Genetics genomic testing and analysis platform include: Cardiology; Dermatology; Ear, Nose, & Throat; Endocrinology; Gastroenterology; Hematology; Hereditary Cancer; Immunology; Malformations; Metabolic Disorders; Nephrology, Neurology; Ophthalmology; and Pulmonology.

Funding

Venture round

On September 1, 2014 Blueprint Genetics closed a venture funding round with $3.9 million in funding from Inventure.

Venture round

On December 31, 2016 Blueprint Genetics closed their second venture funding round with €6 million in funding from Pontos Group and Inventure.

Series A

On July 11, 2017 Blueprint Genomics closed their series A funding round with €14 million in funding from MTIP AG, Creathor Ventures, Inventure, Pontos Group, and Stanford University.

Timeline

People

Name
Role
Related Golden topics

Juha Koskenvuo

Co-Founder

Samuel Myllykangas

Co-Founder

Tero-Pekka Alastalo

Co-Founder

Tommi Lehtonenis

Co-Founder

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Revolutionising Genetic Testing by CEO of Blueprint Genetics | Slush 2015 - YouTube

December 8, 2015

Companies

Company
CEO
Location
Products/Services

References